Genmab — Maj 2020

[AaBforever]

sure..

[E_L]

i was responding to GB. No idea what this crazy stock will do on a day basis. Month-end, Monday closed, who knows...

[Sukkeralf]

Will we see epco data before close today - anybody knows ?

[E_L]

Genmab is presenting data at #ASCO20, including data from the epcoritamab (DuoBody-CD3xCD20) Phase 1/2 dose-escalation study on Friday May 29 at 8 AM EDT.

[E_L]

we are +6 i think, so 14.00

[GeorgeBest]

14:00 CET. Leading oncologists will surely post results on twitter shortly after

[KWC]

Så gevinst hjemtagning før næste stigning

[Legolas23]

Gap-luk

[gentogen]

Beginning Friday, May 29 at 8:00 AM ET
Oral, Poster Discussion, and Poster Sessions, as well as track-based Clinical Science Symposia, will be available on demand.
Registrants will have exclusive access to hundreds of video and slide presentations, as well as discussant commentary for 180 days

[bikube]

KWC - det er sidste dag i måneden, så der er nok nogle fonde, der skal have skiftet ud i depoterne efter den stigning, vi har set.

[GeorgeBest]

hvordan åbner man chat vinduet på iphone?

[GeorgeBest]

har fundet den

[Skyggen]

GB@ Gemmer sig nede i højre hjørne af skærmen

[Skyggen]

Ok fint

[GeorgeBest]

ja, men jeg skulle først trykke på "åbn chat", det var det jeg ikke kunne huske, eller tak

[E_L]

small New trial : Daratumumab, Azacitidine, and Dexamethasone for Treatment of Patients With Recurrent or Refractory Multiple Myeloma Previously Treated With Daratumumab https://www.clinicaltrials.gov/ct2/show/NCT04407442?cond=Multiple+Myeloma&sfpd_s=05%2F15%2F2020&sfpd_d=14&sel_rss=new14

[E_L]

"Giving azacitidine may help increase the levels of CD38 on the tumor cells to increase the function of daratumumab to attach to those tumor cells to help destroy them."

[Darvin]

Det er sgu nogle nærige og dovne investorer vi har omkring DK aktier. Både Gen og Bavarian halter da lidt

[Michael_Almskov]

Darvin. Jeg tror de vågner 14.05 ????

[concillado]

...it's the final countdown!